RIFAXIMIN 550mg. IP

An antibiotic that is used in the treatment of several gastrointestinal and liver diseases. A non-absorbable antibiotic with additional anti-inflammatory and gut microbiota-modulating activity. (Francesca Romana Ponziani, 2016) Possesses broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. (Paolo Caraceni, 2021) A promising option for patients with hepatic encephalopathy due to a good tolerability profile. (Roger Williams, 2005) An effective and safe treatment option for hepatic encephalopathy. (Darego O Maclayton, 2009) Shows superior efficacy compared with lactulose for the treatment of hepatic encephalopathy. (Darego O Maclayton, 2009) A safe and well-tolerated drug for the treatment of minimal and overt hepatic encephalopathy and for the maintenance of hepatic encephalopathy remission. A suitable option for maintenance therapy in patients with cirrhosis and a history of hepatic encephalopathy. (J S Bajaj, 2015) An alternative to conventional oral drugs (nonabsorbable disaccharides, other antibiotics, L-ornithine-L-aspartate (LOLA), and probiotics) for patients with hepatic encephalopathy. (Xianghui Han, 2021) Improves symptoms associated with irritable bowel syndrome, such as bloating, flatulence, stool consistency, and abdominal pain. (Natalya Iorio, 2015) A safe and beneficial addition to the current management options for irritable bowel syndrome. (Natalya Iorio, 2015)